KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Merck (MRK) EBT Margin (2016 - 2025)

Historic EBT Margin for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to 39.04%.

  • Merck's EBT Margin rose 144900.0% to 39.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 33.96%, marking a year-over-year increase of 122500.0%. This contributed to the annual value of 31.07% for FY2024, which is 279300.0% up from last year.
  • Latest data reveals that Merck reported EBT Margin of 39.04% as of Q3 2025, which was up 144900.0% from 31.63% recorded in Q2 2025.
  • Merck's EBT Margin's 5-year high stood at 40.03% during Q3 2021, with a 5-year trough of 35.48% in Q2 2023.
  • Moreover, its 5-year median value for EBT Margin was 28.91% (2021), whereas its average is 24.57%.
  • Its EBT Margin has fluctuated over the past 5 years, first crashed by -662300bps in 2023, then surged by 727600bps in 2024.
  • Merck's EBT Margin (Quarter) stood at 28.91% in 2021, then fell by -12bps to 25.4% in 2022, then plummeted by -155bps to 13.98% in 2023, then surged by 291bps to 26.69% in 2024, then soared by 46bps to 39.04% in 2025.
  • Its last three reported values are 39.04% in Q3 2025, 31.63% for Q2 2025, and 38.01% during Q1 2025.